It looks like pharmaceutical company Pfizer will pay $250 million to settle more than 10,000 lawsuits filed over a heartburn ...
Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, ...
GSK Plc, Pfizer Inc. and other drugmakers must face trials in state court in Delaware after a judge found the evidence ...
Financial terms of the settlements were not immediately disclosed for the discontinued over-the-counter drug that was used to treat heartburn ...
Pfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States over cancer ...
Cook County jury rules heartburn medication Zantac not responsible for plaintiff's cancer; Pfizer settles over 10,000 ...
DOVER — A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling ...
A Chicago jury rejected an Illinois woman’s claim that the discontinued heartburn drug Zantac caused her colon cancer. This ...
A Delaware judge has allowed over 70,000 lawsuits against Zantac to proceed, citing expert witnesses claiming the drug may cause cancer. The drugmakers GSK, Pfizer, Sanofi, and Boehringer Ingelheim ...
Sen. Ron Wyden questions why Pfizer's tax rate over the last few years is significantly less than the U.S. corporate tax rate ...
A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infringed on Pfizer's patents related to cancer treatment.
Along with GSK and Pfizer, Sanofi and Boehringer Ingelheim GmbH have been sued by consumers. After the federal cases were ...